{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:01:52Z","timestamp":1785340912176,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["40401814"],"award-info":[{"award-number":["40401814"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbapap.2026.141153","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:40:51Z","timestamp":1780155651000},"page":"141153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A bond-aware graph neural network integrated with docking, pharmacophore modeling and molecular dynamics for JAK2 inhibitors affinity prediction"],"prefix":"10.1016","volume":"1874","author":[{"given":"Shaghayegh K.","family":"Nezhad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahia V.","family":"Solout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sogol","family":"Meknatkhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahan B.","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2026.141153_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.phrs.2019.03.006","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors","volume":"144","author":"Roskoski","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.bbapap.2026.141153_bb0010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","article-title":"JAK inhibitors in dermatology: the promise of a new drug class","volume":"76","author":"Damsky","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.bbapap.2026.141153_bb0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s13555-020-00363-1","article-title":"Stigmatization and quality of life in patients with psoriasis","volume":"10","author":"Jankowiak","year":"2020","journal-title":"Dermatol. Ther."},{"issue":"3 Pt 1","key":"10.1016\/j.bbapap.2026.141153_bb0020","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.bbapap.2026.141153_bb0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","article-title":"Cytokines in psoriasis","volume":"73","author":"Baliwag","year":"2015","journal-title":"Cytokine"},{"issue":"10281","key":"10.1016\/j.bbapap.2026.141153_bb0030","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"CEM","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbapap.2026.141153_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13317-013-0057-4","article-title":"The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications","volume":"5","author":"Marinoni","year":"2014","journal-title":"Auto Immun Highlights."},{"issue":"19","key":"10.1016\/j.bbapap.2026.141153_bb0040","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bbapap.2026.141153_bb0045","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: a brief overview","volume":"21","author":"Raharja","year":"2021","journal-title":"Clin. Med. (Lond.)"},{"issue":"12","key":"10.1016\/j.bbapap.2026.141153_bb0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/gb-2004-5-12-253","article-title":"The Janus kinases (Jaks)","volume":"5","author":"Yamaoka","year":"2004","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbapap.2026.141153_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107217","article-title":"Small molecule drug discovery targeting the JAK-STAT pathway","volume":"204","author":"Lv","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bbapap.2026.141153_bb0060","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.bbapap.2026.141153_bb0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/1744666X.2022.2039121","article-title":"Comparing available JAK inhibitors for treating patients with psoriasis","volume":"18","author":"Funk","year":"2022","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"6","key":"10.1016\/j.bbapap.2026.141153_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29061363","article-title":"Drug repositioning via graph neural networks: identifying novel JAK2 Inhibitors from FDA-approved drugs through molecular docking and biological validation","volume":"29","author":"Yasir","year":"2024","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bbapap.2026.141153_bb0075","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1158\/2159-8290.CD-22-0952","article-title":"Jak2V617F reversible activation shows its essential requirement in myeloproliferative neoplasms","volume":"14","author":"Dunbar","year":"2024","journal-title":"Cancer Discov."},{"issue":"8","key":"10.1016\/j.bbapap.2026.141153_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080854","article-title":"Roles of JAK2 in aging, inflammation, hematopoiesis and malignant transformation","volume":"8","author":"Perner","year":"2019","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.bbapap.2026.141153_bb0085","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4155\/fmc-2019-0307","article-title":"An overview of drug discovery and development","volume":"12","author":"Berdigaliyev","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bbapap.2026.141153_bb0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/0975-8453.59519","article-title":"Computational approaches for drug design and discovery: an overview","volume":"1","author":"Baldi","year":"2010","journal-title":"Syst. Rev. Pharm."},{"key":"10.1016\/j.bbapap.2026.141153_bb0095","article-title":"Structure-based virtual screening: from classical to artificial intelligence","volume":"8","author":"EHB","year":"2020","journal-title":"Front. Chem."},{"issue":"2","key":"10.1016\/j.bbapap.2026.141153_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/kinasesphosphatases1020008","article-title":"Recent advancements in computational drug design algorithms through machine learning and optimization","volume":"1","author":"Choudhuri","year":"2023","journal-title":"Kinases Phosphat."},{"issue":"18","key":"10.1016\/j.bbapap.2026.141153_bb0105","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1021\/ja00226a005","article-title":"Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins","volume":"110","author":"Cramer","year":"1988","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbapap.2026.141153_bb0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ecoenv.2013.11.019","article-title":"3D-QSAR studies on the toxicity of substituted benzenes to Tetrahymena pyriformis: CoMFA, CoMSIA and VolSurf approaches","volume":"105","author":"Salahinejad","year":"2014","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"5","key":"10.1016\/j.bbapap.2026.141153_bb0115","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3390\/molecules27051496","article-title":"Drug Design\u2014Past, Present, Future","volume":"27","author":"Doytchinova","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bbapap.2026.141153_bb0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/156802610790232260","article-title":"3D-QSAR in drug design--a review","volume":"10","author":"Verma","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"issue":"11","key":"10.1016\/j.bbapap.2026.141153_bb0125","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1016\/j.ejmech.2010.07.062","article-title":"3D-QSAR analysis of human immunodeficiency virus entry-1 inhibitors by CoMFA and CoMSIA","volume":"45","author":"Pirhadi","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbapap.2026.141153_bb0130","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab430","article-title":"Artificial intelligence in drug discovery: applications and techniques","volume":"23","author":"Deng","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"11","key":"10.1016\/j.bbapap.2026.141153_bb0135","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.drudis.2017.08.010","article-title":"From machine learning to deep learning: progress in machine intelligence for rational drug discovery","volume":"22","author":"Zhang","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.bbapap.2026.141153_bb0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1517\/17460441.2016.1146250","article-title":"Use of machine learning approaches for novel drug discovery","volume":"11","author":"Lima","year":"2016","journal-title":"Expert Opin. Drug Discov."},{"issue":"7","key":"10.1016\/j.bbapap.2026.141153_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17575","article-title":"AI in drug discovery and its clinical relevance","volume":"9","author":"Qureshi","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.bbapap.2026.141153_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-022-00593-9","article-title":"A multitask GNN-based interpretable model for discovery of selective JAK inhibitors","volume":"14","author":"Wang","year":"2022","journal-title":"J. Cheminform."},{"issue":"33","key":"10.1016\/j.bbapap.2026.141153_bb0155","doi-asserted-by":"crossref","first-page":"18526","DOI":"10.1039\/D0CP02709J","article-title":"Machine-guided representation for accurate graph-based molecular machine learning","volume":"22","author":"Na","year":"2020","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"35","key":"10.1016\/j.bbapap.2026.141153_bb0160","doi-asserted-by":"crossref","first-page":"20701","DOI":"10.1039\/D0RA02297G","article-title":"Drug\u2013target affinity prediction using graph neural network and contact maps","volume":"10","author":"Jiang","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbapap.2026.141153_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2025.102915","article-title":"Using machine learning in the in-silico design of selective dopamine receptor ligands: advancements in targeted therapies for neurological and psychiatric disorders","volume":"19","author":"Aghdam","year":"2026","journal-title":"Results Chem."},{"issue":"8","key":"10.1016\/j.bbapap.2026.141153_bb0170","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/bioinformatics\/btaa921","article-title":"GraphDTA: predicting drug\u2013target binding affinity with graph neural networks","volume":"37","author":"Nguyen","year":"2020","journal-title":"Bioinformatics"},{"issue":"24","key":"10.1016\/j.bbapap.2026.141153_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15245858","article-title":"Graph neural networks in Cancer and oncology research: emerging and future trends","volume":"15","author":"Gogoshin","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbapap.2026.141153_bb0180","series-title":"Dosage Form Design Parameters","first-page":"731","article-title":"Chapter 21 - computer-aided prediction of pharmacokinetic (ADMET) properties","author":"Chandrasekaran","year":"2018"},{"issue":"9","key":"10.1016\/j.bbapap.2026.141153_bb0185","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1089\/cmb.2019.0323","article-title":"Analysis of the physicochemical properties of Acaricides based on Lipinski\u2019s rule of five","volume":"27","author":"Chen","year":"2020","journal-title":"J. Comput. Biol."},{"issue":"10","key":"10.1016\/j.bbapap.2026.141153_bb0190","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1080\/07391102.2023.2226723","article-title":"Field-based 3D-QSAR for tyrosine protein kinase JAK-2 inhibitors","volume":"42","author":"Andole","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.bbapap.2026.141153_bb0195","article-title":"Molecular representations in AI-driven drug discovery: a review and practical guide","volume":"12","author":"David","year":"2020","journal-title":"J. Chem. Thermodyn."},{"issue":"1","key":"10.1016\/j.bbapap.2026.141153_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/s40537-023-00876-4","article-title":"A review of graph neural networks: concepts, architectures, techniques, challenges, datasets, applications, and future directions","volume":"11","author":"Khemani","year":"2024","journal-title":"J. Big Data"},{"issue":"1","key":"10.1016\/j.bbapap.2026.141153_bb0205","article-title":"Could graph neural networks learn better molecular representation for drug discovery? A comparison study of descriptor-based and graph-based models","volume":"13","author":"Jiang","year":"2021","journal-title":"J. Chem. Thermodyn."},{"key":"10.1016\/j.bbapap.2026.141153_bb0210","article-title":"Semi-supervised classification with graph convolutional networks","author":"Kipf","year":"2017","journal-title":"Int. Conf. Learn. Represent."},{"key":"10.1016\/j.bbapap.2026.141153_bb0215","article-title":"Predicting photodegradation rate constants of water pollutants on TiO2 using graph neural network and combined experimental-graph features","volume":"15(1):19156","author":"V. Solout M, Ghasemi JB.","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbapap.2026.141153_bb0220","series-title":"Neural Message Passing for Quantum Chemistry. International Conference on Machine Learning","author":"Gilmer","year":"2017"},{"issue":"22","key":"10.1016\/j.bbapap.2026.141153_bb0225","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1080\/07391102.2023.2175038","article-title":"New insights into the inhibitory effect of phenol carboxylic acid antioxidants on mushroom tyrosinase by molecular dynamic studies and experimental assessment","volume":"41","author":"Shojazadeh","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"21","key":"10.1016\/j.bbapap.2026.141153_bb0230","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1080\/07391102.2022.2163425","article-title":"A knowledge-based protein-protein interaction inhibition (KPI) pipeline: an insight from drug repositioning for COVID-19 inhibition","volume":"41","author":"Lanjanian","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"4","key":"10.1016\/j.bbapap.2026.141153_bb0235","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1080\/07391102.2021.2020167","article-title":"Biomolecular interactions and binding dynamics of inhibitor arachidonic acid, with tyrosinase enzyme","volume":"41","author":"Shojazadeh","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"10","key":"10.1016\/j.bbapap.2026.141153_bb0240","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1007\/s00894-014-2446-7","article-title":"Combined docking, molecular dynamics simulations and spectroscopic studies for the rational design of a dipeptide ligand for affinity chromatography separation of human serum albumin","volume":"20","author":"Aghaee","year":"2014","journal-title":"J. Mol. Model."},{"issue":"13","key":"10.1016\/j.bbapap.2026.141153_bb0245","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2174\/0929867323666160405112615","article-title":"Insights into the structural features essential for JAK2 inhibition and selectivity","volume":"23","author":"Zhao","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbapap.2026.141153_bb0250","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.csbj.2019.02.006","article-title":"Ligand-based pharmacophore modeling, virtual screening and molecular docking studies for discovery of potential topoisomerase I inhibitors","volume":"17","author":"Pal","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"7","key":"10.1016\/j.bbapap.2026.141153_bb0255","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/17474086.2022.2098105","article-title":"Fedratinib, the first selective JAK2 inhibitor approved for treatment of myelofibrosis - an option beyond ruxolitinib","volume":"15","author":"Saha","year":"2022","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.bbapap.2026.141153_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176679","article-title":"A systematic review of novel cannabinoids and their targets: insights into the significance of structure in activity","volume":"976","author":"Abdollahzadeh Hamzekalayi","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbapap.2026.141153_bb0265","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2174\/1568026611313090006","article-title":"Methods and applications of structure based pharmacophores in drug discovery","volume":"13","author":"Pirhadi","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbapap.2026.141153_bb0270","first-page":"8","article-title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","volume":"1","author":"Ertl","year":"2009","journal-title":"J. Chemother."},{"key":"10.1016\/j.bbapap.2026.141153_bb0275","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"25","key":"10.1016\/j.bbapap.2026.141153_bb0280","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J. Comput. Chem."},{"issue":"7","key":"10.1016\/j.bbapap.2026.141153_bb0285","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa\u2014a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.bbapap.2026.141153_bb0290","first-page":"8","article-title":"The nature of ligand efficiency","volume":"11","author":"Kenny","year":"2019","journal-title":"J. Chemother."},{"issue":"12","key":"10.1016\/j.bbapap.2026.141153_bb0295","doi-asserted-by":"crossref","first-page":"10012","DOI":"10.1021\/acs.jmedchem.4c00197","article-title":"Functional and structural characterization of clinical-stage Janus kinase 2 inhibitors identifies determinants for drug selectivity","volume":"67","author":"Miao","year":"2024","journal-title":"J. Med. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963926000300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963926000300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:29:40Z","timestamp":1785338980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963926000300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1570963926000300"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2026.141153","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A bond-aware graph neural network integrated with docking, pharmacophore modeling and molecular dynamics for JAK2 inhibitors affinity prediction","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbapap.2026.141153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"141153"}}